-transparent.png){kind=logo}
Antisera raised against glutaraldehyde conjugates of glutamate (Glu) and aspartate (Asp) with hemocyanin proved highly specific for their respective unconjugated amino acid haptens when tested in immunocytochemical blocking experiments on sections of the rat spinal cord. In addition, immunocytochemical staining by the Glu antiserum was effectively blocked by quisqualate but not by kainate or N-methyl-D-aspartate (NMDA); staining with the Asp antiserum was effectively blocked by kainate, to a lesser extent by quisqualate, and was not affected by NMDA. These results may be explained by assuming that the specific binding regions of the antibodies tested share certain recognition characteristics with endogenous binding sites or receptors for excitatory amino acids and their agonists.
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
April 1988,
British journal of pharmacology,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
June 2019,
ACS chemical neuroscience,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
January 1988,
Psychopharmacology bulletin,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
March 2000,
Pharmaceutica acta Helvetiae,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
January 1981,
Progress in clinical and biological research,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
September 1994,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
January 1991,
Journal de pharmacie de Belgique,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
September 1995,
The Journal of pharmacology and experimental therapeutics,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
January 1992,
Clinical neuropharmacology,
P Petrusz, and
S L Van Eyck, and
R J Weinberg, and
A Rustioni
September 1992,
Neuroscience,
